Bullish case
$130 to $143
More likely if EPS compounds near 9%, revenue per unit case stays positive, buybacks reduce shares, integration costs stay controlled, and investors keep CCEP near a low-20s forward earnings multiple.
Coca-Cola Europacific Partners plc research snapshot
CCEP AI stock analysis currently reads Coca-Cola Europacific Partners as a high-quality consumer staples bottler with strong Coca-Cola system economics, local route scale, resilient cash generation, and meaningful leverage. At the July 9, 2026 data cutoff, the latest verified quote used here was $106.51, reported market capitalization was about $47.33 billion, and the key issue was whether a stock near its 52-week high still offers enough margin of safety at roughly 22x EPS. This page is informational research and not investment advice.
Current price
$106.51
Market cap
$47.33 billion
AI score
74 / 100
Rating
High-quality bottler, limited margin of safety
Trend status
Bullish but overbought near the 52-week high
Data cutoff (updated weekly)
July 9, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | CCEP bottles, sells, and distributes Coca-Cola system brands and other beverages across Europe, Australia, New Zealand, Pacific markets, Indonesia, and the Philippines. | High |
| Moat | The moat comes from exclusive territory rights, local production and distribution scale, retailer relationships, cold-drink execution, route density, and the Coca-Cola brand system. | High |
| Management | Management has delivered steady shareholder returns through dividends and buybacks, but capital allocation must be judged against leverage, integration, and franchise relationship risk. | Medium-high |
| Financial trend | FY2025 reported revenue was EUR20.9 billion, operating profit was EUR2.79 billion, profit after tax was EUR1.98 billion, and diluted EPS was EUR4.26. | High |
| Valuation | Verified math showed about 22.14x EPS, 20.60x free cash flow per share, 5.20x book value, and a 2.19% dividend yield at the cutoff price. | Medium |
| Technical trend | The stock traded above its main moving averages and near the 52-week high, but RSI near 88.9 made the short-term setup overbought. | Medium-high |
| Risk level | Main risks are Coca-Cola system dependence, consumer weakness, sugar taxes, packaging regulation, currency moves, input costs, leverage, and multiple compression. | Medium-high |
| AI confidence | High confidence for business description, latest annual financials, market cap math, and core risks. Lower confidence for future returns. | High data confidence |
| Investment certainty | Medium certainty. CCEP is a durable operator, but the current price leaves less room for slower growth or a valuation reset. | Medium |
CCEP AI stock forecast
The CCEP AI stock forecast uses scenarios around the $106.51 cutoff price. It is not a guaranteed price target. The bullish case needs steady revenue growth, productivity gains, resilient consumer demand, buyback support, and investors accepting a premium staples multiple. The base case assumes moderate EPS compounding. The bearish case assumes weak volumes, higher costs, regulation, currency pressure, or multiple compression.
$130 to $143
More likely if EPS compounds near 9%, revenue per unit case stays positive, buybacks reduce shares, integration costs stay controlled, and investors keep CCEP near a low-20s forward earnings multiple.
$103 to $112
More likely if EPS grows around 5%, FY2026 revenue growth lands near management targets, free cash flow supports dividends and buybacks, and the stock holds near a 19x to 20x earnings multiple.
$77 to $86
More likely if volume weakens, input costs or taxes pressure margins, net debt limits capital returns, currency translation hurts results, or the market rerates CCEP toward a mid-teens earnings multiple.
CCEP AI technical analysis
CCEP AI technical analysis starts from the $106.51 July 7 quote used for this July 9 static page. Public technical sources showed CCEP above the 50-day and 200-day moving averages, with RSI near 88.9 and MACD positive. Because this page does not fetch live market data, traders should confirm the latest price, volume, and levels on a live chart before acting.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $106.51 | Latest verified quote used for this page as of the July 9, 2026 data cutoff. |
| Near support | $99 to $101 | Area around the 5-day and 10-day moving averages. A pullback into this zone would test whether short-term buyers still support the trend. |
| Secondary support | $92 to $94 | Area around the 50-day moving average and EMA. A break below it would weaken the current momentum setup. |
| Long-term support | $90 to $91 | Area around the 200-day moving average. A sustained break would challenge the longer trend. |
| Near resistance | $110 to $111 | The 52-week high zone shown by public market data. Breakouts need volume confirmation because momentum is already stretched. |
| 50-day moving average | About $92.00 | AltIndex showed the 50-day average above the 200-day average, supporting a bullish trend reading. |
| 200-day moving average | About $90.10 | The stock was above the 200-day moving average at the cutoff, so the long-term trend was still positive. |
| Momentum | RSI 88.9, MACD 2.7 | Momentum was bullish but overbought, which argues against chasing without a defined invalidation plan. |
| Volatility | ATR 14 near $1.10 | Normal daily range is smaller than many growth stocks, but staples can still gap on earnings, regulation, or currency news. |
| Invalidation | Close below $92, then $90 | A close below the 50-day area would reduce confidence in the current trend. A break below the 200-day area would challenge the long trend. |
CCEP AI trading strategy
The CCEP AI trading strategy is a rules-based framework, not personalized advice. It combines filing-backed business evidence, technical confirmation, valuation discipline, and clear invalidation levels.
Look for CCEP to hold above the $99 to $101 near-support area or break the $110 to $111 high zone with better volume before treating momentum as confirmed.
Avoid chasing overbought RSI without a stop. A failed breakout or close below the 50-day area should lower confidence.
If CCEP pulls back toward $92 to $94 without a thesis break, compare the entry price with FY2026 trading updates, free cash flow, dividend coverage, and net debt.
Do not average down solely because the business is defensive. Check leverage, currency, and sugar-tax risk before adding exposure.
Track Q2 2026 results, Europe and API volume, revenue per unit case, comparable operating profit, free cash flow, buyback pace, dividend growth, and net debt.
Lower the rating if volume weakens while valuation remains near a premium staples multiple.
Investment research summary
CCEP gets paid to make, move, sell, and merchandise Coca-Cola system beverages and selected partner brands across local markets where availability, service, and cold-drink execution matter.
The moat is territory rights, route density, retailer access, local manufacturing scale, customer service routines, cold-chain execution, and the Coca-Cola brand system. CCEP benefits from the brand but does not fully own it.
The thesis can fail if Coca-Cola system economics shift against bottlers, consumers trade down, sugar or packaging rules tighten, input costs rise, currency weakens, leverage limits buybacks, or investors stop paying a defensive premium.
Damian Gammell and the board have emphasized growth, productivity, dividends, and buybacks. Capital allocation looks shareholder friendly, but it must remain balanced against debt and local market reinvestment needs.
Non-alcoholic ready-to-drink beverages remain a large repeat-purchase category. The long trend is stable rather than explosive, with growth tied to pricing, mix, zero-sugar products, energy drinks, away-from-home demand, and emerging market execution.
At roughly 22.14x EPS and 20.60x free cash flow per share, CCEP is not priced like a distressed staples company. The margin of safety depends on steady compounding, disciplined leverage, and not overpaying near technical highs.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| CCEP price | $106.51 quote on July 7, 2026 | Markets Insider quote snapshot | July 9, 2026 |
| Market capitalization | $47.33 billion, verified as $106.51 x 443.22 million shares | financial_rigor.py and Markets Insider | July 9, 2026 |
| Shares outstanding | 443.22 million in the market quote snapshot, 448.65 million at StockAnalysis | Markets Insider and StockAnalysis | July 9, 2026 |
| FY2025 revenue | EUR20.9 billion reported, cross-checked against $23.65 billion USD third-party annual revenue | CCEP FY2025 results and AlphaQuery | July 9, 2026 |
| FY2025 operating profit | EUR2.793 billion reported operating profit | CCEP FY2025 results | July 9, 2026 |
| FY2025 profit after tax | EUR1.979 billion reported, cross-checked against about $2.20 billion USD third-party net income | CCEP FY2025 results, Macrotrends, and AlphaQuery | July 9, 2026 |
| FY2025 diluted EPS | EUR4.26 reported diluted EPS | CCEP FY2025 results | July 9, 2026 |
| Net debt proxy | EUR9.618 billion closing borrowings less cash and short-term investments | CCEP FY2025 results and financial_rigor.py cross-validation | July 9, 2026 |
| Valuation math | 22.14x EPS, 5.20x book, 20.60x FCF per share, 2.19% dividend yield | financial_rigor.py valuation verification | July 9, 2026 |
| Technical indicators | RSI 88.9, 50-day SMA $92.00, 200-day SMA $90.10, MACD 2.7, ATR 1.1 | AltIndex technical snapshot | July 9, 2026 |
| Q1 2026 update | Q1 2026 trading update confirmed continued shareholder returns and management confidence in mid-term objectives | CCEP Q1 2026 Trading Update | July 9, 2026 |
This CCEP AI stock analysis is an informational tool for research and education only. It is not investment advice, a recommendation, or a guarantee of future performance. Forecast ranges are scenarios based on available data as of July 9, 2026 and can be wrong.